SLC5A2 and diabetic ketoacidosis: SGLT-2 inhibitor-related adverse events that can complicate their use include transient mild dehydration, urinary tract infections, genital mycotic infections, and rarely euglycemic diabetic ketoacidosis (DKA) [77].